Description of the Population With Genitourinary Tumors and COVID-19

The study will be carried out in Spanish hospitals, with principal investigators belonging to
the medical oncology services of the SOGUG group (Spanish Group of Genitourinary Oncology),
who will act as promoter. Once the patients have been selected, the variables of interest
will be collected and studied. The main variables to record will be:

1. Patient characteristics

2. Hospital center where the patient is recruited

3. Pathological history:

Concomitant pathology Usual drug treatment

4. Tumor pathology:

Tumor type, histology, and stage (initial and at diagnosis of infection) Cancer
diagnosis date Active cancer treatment or follow-up Participation in clinical trial Type
of treatment most recently received for the infection (Surgery; Radiotherapy;
Chemotherapy, Immunotherapy ...) Treatment lines, initiation and last dose received of
the most recent most recent cancer treatment

5. COVID-19 infection:

Confirmation date of COVID-19 infection PCR (Polymerase Chain Reaction) diagnostic test
Immunoglobulin G (IgG) or Immunoglobulin M (IgM) serological diagnostic test Present
symptoms, analytical alterations, thrombosis associated with COVID-19 infection,
complications of infection Date of onset and disappearance of symptoms Days of fever and
cough Radiological examination at the time of greatest severity Treatments received for
COVID-19 Status upon discharge Date of discharge / exitus Negative presence of virus by
PCR and PCR date

6. For patients who are receiving or have received immunotherapy treatments, additional
information will be collected:

Immunotherapy treatment line and type Start / end date and last dose previous infection
of the treatment with immunotherapy Adverse effects

7. Prospective follow-up data (6 months from patient inclusion):

Date of start or restart of cancer treatment after infection Change / suspension of cancer
treatment after COVID-19 Date of surgery in neoadjuvant patients Recurrence of COVID-19 Best
response obtained Date of progression to cancer treatment Current status and date of last
contact The study will use the data obtained from the patient's medical history, with no
plans to use other sources.

The assignment of a patient to a specific therapeutic strategy has already been decided in
advance by the usual clinical practice of medicine; The decision to prescribe a specific
treatment is clearly dissociated from the decision to include a patient in the study. No
intervention will be applied to patients, whether diagnostic or follow-up, that is not the
usual clinical practice. Epidemiological methods will be used to analyze the collected data.